FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplemental application fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Partial-onset Seizures
• Postherpetic Neuralgia

Drugs mentioned

• LYRICA CR (PREGABALIN)

Snippet

SUPPL AP for LYRICA CR (PREGABALIN)